healthcare

Private Equity

Investcorp takes stakes in China healthcare companies

The $32 billion multi-strategy alternative investment firm Investcorp announced the launch of a new platform dedicated to investment in Chinese…

Hedge Funds

Hedge funds help biotech pioneer Palleon raise $100m

Hedge fund Matrix Capital Management led a $100 million Series B round for Palleon Pharmaceuticals, a leader in the emerging…

Private Equity

PE powers cancer-focused Neogene’s Series A to $110m

In the latest example of the life science sector's appeal to alt players, T-cell . . . Continue Reading With…

Private Equity

KKR veteran launches healthcare private equity firm

Jim Momtazee, a 21-year veteran of KKR, has launched his own investment firm, Patient Square Capital, with an aim of…

Featured

Blackstone Life Sciences funds R&D for Alnylam

Blackstone and Alnylam Pharmaceuticals closed the R&D funding component of the companies’

Featured

Sphera Healthcare makes key U.S. hires

Tel Aviv-headquartered Sphera Funds Management has added to the New York office of its healthcare hedge fund unit Sphera Healthcare,…

Private Equity

Luxembourg PE player funds U.S. cancer diagnostics developer

The fight against cancer received a multi-million dollar boost from GEM Global Yield, an investment vehicle operated by $3.4 billion…

Featured

Healthy hedges for a new equity era

This past week was a bit of mixed bag for earnings for pharmaceutical companies, with giant Pfizer beating estimates as…

Featured

Insurer Ping An to launch healthcare joint ventures with Shionogi

Ping An Insurance (Group) Company of China Ltd and Shionogi (Hong Kong) Company Ltd agreed on July 27 to launch…

Manager News

Blackstone taps former FDA chief as senior advisor

Dr. Mark McClellan, a physician and economist who has served both the commissioner of the U.S. Food and Drug Administration…

Back to top button